Cited by 6,552Cardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Open access

Bardy, Gust H., Lee, Kerry L., Mark, Daniel B., Poole, Jeanne E., Packer, Douglas L., Boineau, Robin, Domanski, Michael, Troutman, Charles, Anderson, Jill, Johnson, George, McNulty, Steven E., Clapp-Channing, Nancy, Davidson-Ray, Linda D., Fraulo, Elizabeth S., Fishbein, Daniel P., Luceri, Richard M., Ip, John H.·2005·New England Journal of Medicine

DOI 10.1056/nejmoa043399

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter-defibrillator (ICD) has been proposed to improve the prognosis in such patients. METHODS: We randomly assigned 2521 patients with New York Heart Association (NYHA) class II or III CHF and a left ventricular ejection fraction (LVEF) of 35 percent or less to conventional therapy for CHF plus placebo (847 patients), conventional therapy plus amiodarone (845 patients), or conventional therapy plus a conservatively programmed, shock-only, single-lead ICD (829 patients). Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause. RESULTS: The median LVEF in patients was 25 percent; 70 percent were in NYHA class II, and 30 percent were in class III CHF. The cause of CHF was ischemic in 52 percent and nonischemic in 48 percent. The median follow-up was 45.5 months. There were 244 deaths (29 percent) in the placebo group, 240 (28 percent) in the amiodarone group, and 182 (22 percent) in the ICD group. As compared with placebo, amiodarone was associated with a similar risk of death (hazard ratio, 1.06; 97.5 percent confidence interval, 0.86 to 1.30; P=0.53) and ICD therapy was associated with a decreased risk of death of 23 percent (0.77; 97.5 percent confidence interval, 0.62 to 0.96; P=0.007) and an absolute decrease in mortality of 7.2 percentage points after five years in the overall population. Results did not vary according to either ischemic or nonischemic causes of CHF, but they did vary according to the NYHA class. CONCLUSIONS: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa043399

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310

Flagged first, then by citations

Show all 20 references

Research works printed but not linked: 1

10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 901–1,000 of 1,019

New developments in atrial antiarrhythmic drug therapy
Burashnikov, A., & Antzelevitch, C. N. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.245 · Cited by 64
Examining the safety of amiodarone
Santangeli, P., Biase, L. D., BURKHARDT, J. D., Bai, R., Mohanty, P. K., Pump, A., & Natale, A. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.660915 · Cited by 64
Anxiety and Depression in Implanted Cardioverter-Defibrillator Recipients and Heart Failure: A Review
Freedenberg, V. A., Thomas, S. A., & Friedmann, E. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.08.008 · Cited by 63
Multicenter Study of the Effectiveness of Implantable Cardioverter Defibrillators in Children and Young Adults With Heart Disease
Bergen, N. H. V., Atkins, D. L., Dick, M., Bradley, D. J., Etheridge, S. P., Saarel, E. V., Fischbach, P., Balaji, S., Sreeram, N., Evans, W. N., et al. (2011) · Pediatric Cardiology · doi:10.1007/s00246-010-9866-7 · Cited by 64
Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register
Weeke, P. E., Johansen, J. B., Jørgensen, O. D., Nielsen, J. C., Møller, M. B., Videbæk, R., Hojgaard, M. V., Riahi, S., & Jacobsen, P. K. (2013) · EP Europace · doi:10.1093/europace/eut017 · Cited by 65
Tpeak-to-Tend interval corrected for heart rate: A more precise measure of increased sudden death risk?
Chua, K., Rusinaru, C., Reinier, K., Uy‐Evanado, A., Chugh, H. S., Gunson, K., Jui, J., & Chugh, S. S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.08.022 · Cited by 64
Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators
Kramer, D. B., Kennedy, K. F., Noseworthy, P. A., Buxton, A. E., Josephson, M. E., Normand, S. T., Spertus, J. A., ZIMETBAUM, P. J., Reynolds, M. R., & Mitchell, S. L. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.000054 · Cited by 64
Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology
Normand, C., Kaye, D. M., Povsic, T. J., & Dickstein, K. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32216-5 · Cited by 67
The top 10 reasons to avoid defibrillation threshold testing during ICD implantation
Viskin, S., & Rosso, R. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.01.006 · Cited by 64
Shock as a Determinant of Poor Patient‐Centered Outcomes in Implantable Cardioverter Defibrillator Patients: Is There More to It Than Meets the Eye?
PEDERSEN, S. S., VAN DEN BROEK, K. C., VAN DEN BERG, M., & THEUNS, D. A. M. J. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02845.x · Cited by 63
Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention
Marshall, A., Cheetham, A., George, R. S., Mason, M. J., & Kelion, A. D. (2012) · Heart · doi:10.1136/heartjnl-2012-302321 · Cited by 63
Prediction of Sudden Cardiac Death Manifesting With Documented Ventricular Fibrillation or Pulseless Ventricular Tachycardia
Chugh, S. S., Reinier, K., Uy‐Evanado, A., Chugh, H. S., Elashoff, D. A., Young, C., Salvucci, A., & Jui, J. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.02.004 · Cited by 63
Recent successes in heart failure treatment
Lam, C. S. P., Docherty, K. F., Ho, J. E., McMurray, J. J. V., Myhre, P. L., & Omland, T. (2023) · Nature Medicine · doi:10.1038/s41591-023-02567-2 · Cited by 68
Cardiac Resynchronization Therapy:
Lilli, A., Ricciardi, G., Porciani, M. C., Perini, A. P., Pieragnoli, P., Musilli, N., Colella, A., Pace, S. D., Michelucci, A., Turreni, F., et al. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00870.x · Cited by 63
Comparison of Three-Year Outcomes After Primary Percutaneous Coronary Intervention in Patients With Left Ventricular Ejection Fraction <40% Versus ≥40% (from the HORIZONS-AMI Trial)
Daneault, B., Généreux, P., Kirtane, A. J., Witzenbichler, B., Guagliumi, G., Paradis, J., Fahy, M. P., Mehran, R., & Stone, G. W. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.040 · Cited by 63
Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart Failure
Kawashiro, N., Kasanuki, H., Ogawa, H., Matsuda, N., & Hagiwara, N. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0323 · Cited by 64
Long-Term Arrhythmia-Free Survival in Patients With Severe Left Ventricular Dysfunction and No Inducible Ventricular Tachycardia After Myocardial Infarction
Zaman, S. J., Narayan, A., Thiagalingam, A., Sivagangabalan, G., Thomas, S. P., Ross, D. L., & Kovoor, P. (2013) · Circulation · doi:10.1161/circulationaha.113.005146 · Cited by 63
Heart Failure Management in Skilled Nursing Facilities
Jurgens, C. Y., Goodlin, S. J., Dolansky, M. A., Ahmed, A., Fonarow, G. C., Boxer, R. S., Arena, R. A., Blank, L., Buck, H. G., Cranmer, K. W., et al. (2015) · Circulation Heart Failure · doi:10.1161/hhf.0000000000000005 · Cited by 66
Registro Español de Desfibrilador Automático Implantable. Primer Informe Oficial del Grupo de Trabajo de Desfibrilador Implantable de la Sociedad Española de Cardiología (años 2002-2004)
Peinado, R., Arenal, Á., Arribas, F., Torrecilla, E. G., Álvarez, M., Ormaetxe, J. M., & Pérez‐Castellano, N. (2005) · Revista Española de Cardiología · doi:10.1016/s0300-8932(05)74074-4 · Cited by 63
The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients
Tsai, V., Cooper, J. M., Garan, H., Natale, A., Ptaszek, L. M., Ellinor, P. T., Hickey, K. T., Downey, R. A., Zei, P. C., Hsia, H. H., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.814525 · Cited by 62
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
Heidenreich, P. A., Fonarow, G. C., Breathett, K. K., Jurgens, C. Y., Pisani, B., Pozehl, B., Spertus, J. A., Taylor, K. G., Thibodeau, J. T., Yancy, C. W., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000099 · Cited by 61
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia
Takase, B., Ikeda, T., Shimizu, W., Abe, H., Aiba, T., Chinushi, M., Koba, S., KUSANO, K. F., Niwano, S., Takahashi, N., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0827 · Cited by 68
Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score
van Rees, J. B., Borleffs, C. J. W., van Welsenes, G. H., van der Velde, E. T., Bax, J. J., van Erven, L., Putter, H., van der Bom, J. G., & Schalij, M. J. (2012) · Heart · doi:10.1136/heartjnl-2011-300632 · Cited by 60
Implantable Cardioverter-Defibrillator Efficacy in Patients With Heart Failure and Left Ventricular Dysfunction (from the MADIT II Population)
Zaręba, W., Piotrowicz, K., McNitt, S. A., & Moss, A. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.02.021 · Cited by 62
Outpatient Continuous Parenteral Inotropic Therapy as Bridge to Transplantation in Children With Advanced Heart Failure
Price, J. F., Towbin, J. A., Dreyer, W. J., Moffett, B. S., Kertesz, N. J., Clunie, S. K., & Denfield, S. W. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.11.001 · Cited by 62
Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD thErapy (ADVANCE-D) Trial results
Santini, M., Lunati, M., Defaye, P., Mermi, J., Proclemer, A., del Castillo-Arroys, S., Molon, G., Santi, E., Santo, T. D., Navarro, X., et al. (2010) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-009-9454-z · Cited by 62
Heart Rate Variability and Non-Linear Dynamics in Risk Stratification
Perkiömäki, J. S. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00081 · Cited by 62
Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07
Proclemer, A., Ghidina, M., Gregori, D., Facchin, D., Rebellato, L., Fioretti, P., & Brignole, M. (2008) · EP Europace · doi:10.1093/europace/eun370 · Cited by 61
Age‐Specific Differences in Women with Implantable Cardioverter Defibrillators: An International Multi Center Study
Vazquez, L. D., Kuhl, E. A., Shea, J. B., Kirkness, A., Lemon, J., Whalley, D. W., CONTI, J. B., & Sears, S. F. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01223.x · Cited by 62
Taquicardia ventricular en la enfermedad coronaria
Benito, B., & Josephson, M. E. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.03.027 · Cited by 62
Management of Recalled Pacemakers and Implantable Cardioverter-Defibrillators
Amin, M. S., Matchar, D. B., Wood, M. A., & Ellenbogen, K. A. (2006) · JAMA · doi:10.1001/jama.296.4.412 · Cited by 62
Resource Loss Predicts Depression and Anxiety Among Patients Treated With an Implantable Cardioverter Defibrillator
Luyster, F. S., Hughes, J. W., Waechter, D., & Josephson, R. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000227722.92307.35 · Cited by 61
Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts
Peek, N. B., Hindricks, G., Akbarov, A., Tijssen, J. G. P., Jenkins, D. A., Kapacee, Z., Parkes, L. M., van der Geest, R. J., Longato, E., Sprague, D. T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae326 · Cited by 61
Incidence of Appropriate Shock in Implantable Cardioverter-Defibrillator Patients With Improved Ejection Fraction
Naksuk, N., Saab, A., Li, J.-M., Florea, V. G., Akkaya, M., Anand, I. S., Benditt, D. G., & Adabağ, S. (2013) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2013.04.007 · Cited by 61
Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization
Perego, G. B., Landolina, M., Vergara, G., Lunati, M., Zanotto, G., Pappone, A., LONARDI, G., Speca, G., Iacopino, S., VARBARO, A., et al. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9303-5 · Cited by 61
The Relationship between Warfarin, Aspirin, and Clopidogrel Continuation in the Peri-procedural Period and the Incidence of Hematoma Formation after Device Implantation
Thal, S. G., Moukabary, T., Boyella, R., Shanmugasundaram, M., Pierce, M., Thai, H. M., & Goldman, S. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02674.x · Cited by 61
An ECG index of myocardial scar enhances prediction of defibrillator shocks: An analysis of the Sudden Cardiac Death in Heart Failure Trial
Strauss, D. G., Poole, J. E., Wagner, G. S., Selvester, R. H. S., Miller, J. M., Anderson, J., Johnson, G. W., McNulty, S. E., Mark, D. B., Lee, K. L., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.09.071 · Cited by 61
Self-citation
Age and gender trends in implantable cardioverter defibrillator utilization: A population based study
Lin, G., Meverden, R. A., Hodge, D. O., Uslan, D. Z., Hayes, D. L., & Brady, P. A. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9213-6 · Cited by 61
Implantable cardioverter-defibrillator longevity under clinical circumstances: An analysis according to device type, generation, and manufacturer
Thijssen, J., Borleffs, C. J. W., van Rees, J. B., Man, S., de Bie, M. K., Venlet, J., van der Velde, E. T., van Erven, L., & Schalij, M. J. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.11.022 · Cited by 61
Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD
Deo, R., Shou, H., Soliman, E. Z., Yang, W. P., Arkin, J. M., Zhang, X., Townsend, R. R., Go, A. S., Shlipak, M. G., & Feldman, H. I. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101045 · Cited by 61
Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy
Narayanan, M. A., Vakil, K. P., Reddy, Y. N. V., Baskaran, J., Deshmukh, A. J., Benditt, D. G., & Adabağ, S. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.02.006 · Cited by 62
Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies
Verma, A., Kilicaslan, F., Martin, D. O., Minor, S., Starling, R., Marrouche, N. F., Almahammed, S., Wazni, O. M., Duggal, S., Zuzek, R., et al. (2005) · Heart · doi:10.1136/hrt.2004.058198 · Cited by 61
Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy
Kolb, C., Sturmer, M., Sick, P. B., Reif, S., Davy, J. M., Molon, G., SCHWAB, J. O., Mantovani, G., Dan, D., Lennerz, C., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.05.015 · Cited by 60
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators
Lee, D. S., Hardy, J., Yee, R. K., Healey, J. S., BIRNIE, D. H., Simpson, C. S., Crystal, E., Mangat, I., Nanthakumar, K., Wang, X., et al. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002414 · Cited by 60
Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity
Schaer, B. A., Koller, M., Sticherling, C., Altmann, D., Joerg, L., & Osswald, S. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.09.013 · Cited by 60
The implantable cardioverter defibrillator: its history, current psychological impact and future
Matchett, M., Sears, S. F., Hazelton, G., Kirian, K., Wilson, E., & Nekkanti, R. (2008) · Expert Review of Medical Devices · doi:10.1586/17434440.6.1.43 · Cited by 59
Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial—a prospective multicentre study
Erkapic, D., Sperzel, J., Stiller, S., Meltendorf, U., Mermi, J., Wegscheider, K., Hügl, B. J., & for the INSURE Investigators (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs177 · Cited by 60
Risk Factors for Implantable Defibrillator Lead Fracture in a Recalled and a Nonrecalled Lead
Morrison, T. B., Rea, R. F., Hodge, D. O., Crusan, D. J., Koestler, C., Asirvatham, S. J., BRADLEY, D., Shen, W. K., Munger, T. M., Hammill, S. C., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01683.x · Cited by 60
Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis
Lauridsen, T. K., Park, L., Tong, S. Y. C., Selton‐Suty, C., Peterson, G., Cecchi, E., Afonso, L., Habib, G., Paré, C., Tamin, S. S., et al. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.003397 · Cited by 60
Heart Rate Turbulence and Death Due to cardiac decompensation in Patients with Chronic Heart Failure
Moore, R. K. G., Groves, D. G., Barlow, P. E., Fox, K. A. A., Shah, A. M., Nolan, J., & Kearney, M. T. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.11.012 · Cited by 61
Can Monitoring of Intrathoracic Impedance Reduce Morbidity and Mortality in Patients with Chronic Heart Failure? Rationale and Design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)
Braunschweig, F., Ford, I., Conraads, V. M., Cowie, M., Jondeau, G., Kautzner, J., Lunati, M., Aguilera, R. M., Yu, C., Marijianowski, M. M. H., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.06.016 · Cited by 60
The Safety of Amiodarone in Patients With Heart Failure
Torp-Pedersen, C. T., Metra, M., Spark, P. H., Lukas, M. A., Moullet, C., Scherhag, A. W., Michel Komajda, N., Cleland, J. G. F., Remme, W. J., Lenarda, A. D., et al. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.02.009 · Cited by 60
Risk Stratification of Mortality in Patients With Heart Failure and Left Ventricular Ejection Fraction >35%
Cygankiewicz, I., Zareba, W., Vazquez, R., Bayes-Genis, A., Pascual, D., Macaya, C., Almendral, J., Fiol, M., Bardaji, A., Gonzalez-Juanatey, J. R., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.061 · Cited by 58
Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices
Lin, A. Y., Saul, T., Aldaas, O. M., Lupercio, F. A., Ho, G., Pollema, T. L., Pretorius, V. G., & Birgersdotter-Green, U. M. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.11.003 · Cited by 63
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
Knops, R. E., van der Stuijt, W., Delnoy, P. P. H. M., Boersma, L. V. A., Kuschyk, J., El-Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kääb, S., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.057816 · Cited by 59
In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis
Andongma, B. T., Huang, Y., Chen, F., Tang, Q., Yang, M., Chou, S., Li, X., & He, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.01.019 · Cited by 59
Risk stratification for sudden death in patients with coronary artery disease
Buxton, A. E. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.02.016 · Cited by 58
Incidence of Defibrillator Shocks After Elective Generator Exchange Following Uneventful First Battery Life
Merchant, F. M., Jones, P. W., Wehrenberg, S., Lloyd, M. S., & Saxon, L. A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001289 · Cited by 59
Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death
Piccini, J. P., Horton, J. R., Shaw, L. K., Al‐Khatib, S. M., Lee, K. L., Iskandrian, A. E., & Borges‐Neto, S. (2008) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.776484 · Cited by 59
Self-citation
Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study
Bhardwaj, A., Rehman, S., Mohammed, A. A., Baggish, A. L., Moore, S. A., & Januzzi, J. L. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.01.005 · Cited by 59
How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?
Sankaranarayanan, R., Kirkwood, G. J., Visweswariah, R., & Fox, D. J. (2015) · Current Cardiology Reviews · doi:10.2174/1573403x10666140902143020 · Cited by 63
Imaging-Based Simulations for Predicting Sudden Death and Guiding Ventricular Tachycardia Ablation
Trayanova, N. A., Pashakhanloo, F., Wu, K. C., & Halperin, H. R. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.004743 · Cited by 59
Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM‐ICD): Rationale and Design of an RCT Currently Underway
Serber, E. R., Fava, J. L., Christon, L., Buxton, A. E., Goldberger, J. J., Gold, M. R., Rodrigue, J. R., & Frisch, M. B. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12820 · Cited by 58
Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models
Gulati, G., Upshaw, J., Wessler, B. S., Brazil, R. J., Nelson, J., Klaveren, D. V., Lundquist, C. M., Park, J. G., McGinnes, H., Steyerberg, E. W., et al. (2022) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.121.008487 · Cited by 62
Clustering of Device‐Related Concerns and Type D Personality Predicts Increased Distress in ICD Patients Independent of Shocks1
Pedersen, S. S., Theuns, D. A. M. J., Erdman, R. A. M., & Jordaens, L. J. L. M. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00921.x · Cited by 58
Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: Safety of withholding the implant
Penela, D., Acosta, J., Aguinaga, L., Tercedor, L., Ordóñez, A., Fernández‐Armenta, J., Andreu, D., Sánchez, P., Cabanelas, N., Tolosana, J. M., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.011 · Cited by 58
Predictors of Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy in Primary Prevention Patients with Ischemic and Nonischemic Cardiomyopathy
Verma, A., Sarak, B., KAPLAN, A. J., Oosthuizen, R., Beardsall, M., Wulffhart, Z. A., HIGENBOTTAM, J., & Khaykin, Y. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02566.x · Cited by 58
Post-Exercise Assessment of Cardiac Repolarization Alternans in Patients With Coronary Artery Disease Using the Modified Moving Average Method
Slawnych, M., Nieminen, T. V. M., Kähönen, M. A. P., Kavanagh, K. M., Lehtimäki, T. J., Ramadan, D., Viik, J., Aggarwal, S., Lehtinen, R., Ellis, L., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.026 · Cited by 58
Surgery for Ventricular Tachycardia in Patients Undergoing Left Ventricular Reconstruction by the Dor Procedure
Sartipy, U., Albåge, A., Strååt, E., Insulander, P., & Lindblom, D. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.06.058 · Cited by 58
Relationships between emerging measures of heart failure processes of care and clinical outcomes
Hernandez, A. F., Hammill, B. G., Peterson, E. D., Yancy, C. W., Schulman, K. A., Curtis, L. H., & Fonarow, G. C. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.12.024 · Cited by 58
Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation
Zaręba, W., Steinberg, J. S., McNitt, S. A., Daubert, J. P., Piotrowicz, K., & Moss, A. J. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.02.012 · Cited by 58
El anciano con cardiopatía terminal
Martínez‐Sellés, M., Vidán, M. T., López‐Palop, R., Rexach, L., Sánchez, E., Datino, T., Cornide, M., Carrillo, P., Ribera, J. M., Dı́az-Castro, Ó., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70898-x · Cited by 59
Impact of ICD Artifact Burden on Late Gadolinium Enhancement Cardiac MR Imaging in Patients Undergoing Ventricular Tachycardia Ablation
Mesubi, O. O., Ahmad, G., Jeudy, J. J., Jiménez, A., Kuk, R. S., SALIARIS, A. P., See, V. Y., Shorofsky, S. R., & Dickfeld, T. L. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12405 · Cited by 58
Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Mitchell, J. E., Hellkamp, A. S., Mark, D. B., Anderson, J., Poole, J. E., Lee, K. L., & Bardy, G. H. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.10.022 · Cited by 58
Self-citation
Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy
Singh, M., Wang, N. C., Jain, S. K., Voigt, A., Saba, S., & ADELSTEIN, E. C. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.079 · Cited by 57
Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis
Auricchio, A., Hudnall, J. H., Schloss, E. J., Sterns, L. D., Kurita, T., Meijer, A., Fagan, D. H., & Rogers, T. B. (2017) · EP Europace · doi:10.1093/europace/euw415 · Cited by 58
Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Kusumoto, F. M., Bailey, K. R., Chaouki, A. S., Deshmukh, A. J., Gautam, S., Kim, R. J., Kramer, D. B., Lambrakos, L. K., Nasser, N. H., & Sorajja, D. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.037 · Cited by 59
Quality of life and psychological status of patients with implantable cardioverter defibrillators
Friedmann, E., Thomas, S. A., Inguito, P., Kao, C., Metcalf, M. D., Kelley, F. J., & Gottlieb, S. S. (2007) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-006-9053-1 · Cited by 58
Correlates of Patient Acceptance of the Cardioverter Defibrillator: Cross‐Validation of the Florida Patient Acceptance Survey in Danish Patients
Pedersen, S. S., Spindler, H., Johansen, J. B., Mortensen, P. T., & Sears, S. F. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01158.x · Cited by 58
The need for increased pragmatism in cardiovascular clinical trials
Usman, M., Spall, H. G. C. V., Greene, S. J., Pandey, A., McGuire, D. K., Ali, Z. A., Mentz, R. J., Fonarow, G. C., Spertus, J. A., Anker, S. D., et al. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00705-w · Cited by 60
Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction
Schou, M., Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Kitzman, D. W., Shah, S. J., Verma, S., Patel, S., Chinnakondepalli, K., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.04.038 · Cited by 63
End‐of‐Life Care in Patients with Implantable Cardioverter Defibrillators: A MADIT‐II Substudy
Sherazi, S., McNitt, S. A., Aktaş, M. K., Polonsky, B., Shah, A. H., Moss, A. J., Daubert, J. P., & Zaręba, W. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12188 · Cited by 57
Association Between Frequency of Atrial and Ventricular Ectopic Beats and Biventricular Pacing Percentage and Outcomes in Patients With Cardiac Resynchronization Therapy
Ruwald, M. H., Mittal, S., Ruwald, A., Aktaş, M. K., Daubert, J. P., McNitt, S. A., Al‐Ahmad, A., Jøns, C., Kutyifa, V., Steinberg, J. S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1177 · Cited by 55
Mechanisms of sudden cardiac death
Israel, C. W. (2014) · Indian Heart Journal · doi:10.1016/j.ihj.2014.01.005 · Cited by 57
Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Study
Varma, N. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.051 · Cited by 57
The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia
Rozner, M. A. (2007) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32814f1c4a · Cited by 57
Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure
Smilde, T. D. J., van Veldhuisen, D. J., & van den Berg, M. P. (2009) · Clinical Research in Cardiology · doi:10.1007/s00392-009-0747-0 · Cited by 57
Patient satisfaction and suggestions for improvement of remote ICD monitoring
Petersen, H. H., Larsen, M. C. J., Nielsen, O. W., Kensing, F., & Svendsen, J. H. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9675-4 · Cited by 57
Predicting and Preventing Sudden Cardiac Death
Estes, N. A. M. (2011) · Circulation · doi:10.1161/circulationaha.110.974170 · Cited by 57
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems
Biffi, M., Ziacchi, M., Bertini, M., Sangiorgi, D., Corsini, D., Martignani, C., Diemberger, I., & Boriani, G. (2008) · EP Europace · doi:10.1093/europace/eun240 · Cited by 57
Pharmacologic Management of Atrial Fibrillation: Established and Emerging Options
Kalus, J. S. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s6-b.10 · Cited by 57
Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge
Weissler‐Snir, A., Adler, A., Williams, L. K., Gruner, C., & Rakowski, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw268 · Cited by 59
Cardiac Arrest: the Changing Incidence of Ventricular Fibrillation
Keller, S. P., & Halperin, H. R. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0392-z · Cited by 58
Bundesärztekammer Kassenärztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
VersorgungsLeitlinie, N. (2011) · Cited by 58
Treatment options in myocarditis and inflammatory cardiomyopathy
Maisch, B., & Alter, P. J. (2018) · Herz · doi:10.1007/s00059-018-4719-x · Cited by 60
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
Iwasaki, Y., Noda, T., Akao, M., Fujino, T., Hirano, T., Inoue, K., KUSANO, K. F., Nagai, T., Satomi, K., Shinohara, T., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-24-0073 · Cited by 57
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 109
Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy
Demirel, F., Adiyaman, A., Timmer, J. R., Dambrink, J. E., Kok, M., Boeve, W. J., & Elvan, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.132 · Cited by 56
Female-Specific Education, Management, and Lifestyle Enhancement for Implantable Cardioverter Defibrillator Patients: The FEMALE-ICD Study: PSYCHOSOCIAL TREATMENT FOR WOMEN WITH ICDs
VAZQUEZ, L. D., CONTI, J. B., & SEARS, S. F. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02787.x · Cited by 51
Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT)
Martin, D. T., McNitt, S., Nesto, R. W., Rutter, M. K., & Moss, A. J. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959510 · Cited by 51

Authors: Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., Luceri, R. M., & Ip, J. H.
Affiliations: The Seattle Institute for Cardiac Research (US)
Duke University (US)
University of Washington (US)
Mayo Clinic (US)
National Heart, Lung, and Blood Institute (US)
ORCID: Lee, Kerry L.
Mark, Daniel B.
Poole, Jeanne E.
Packer, Douglas L.
Boineau, Robin
Davidson-Ray, Linda D.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-01-20
Volume: 352
Issue: 3
Pages: 225-237
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa043399
OpenAlex: W2075175982
Semantic Scholar: cf04075b17dbae3fc6bc9a3a2f9673f9fad192ea
Cited by: 6,552
References: 20
Citations by year: 2026: 126 · 2025: 170 · 2024: 173 · 2023: 186 · 2022: 231 · 2021: 236 · 2020: 261 · 2019: 285 · 2018: 287 · 2017: 394 · 2016: 326 · 2015: 355 · 2014: 335 · 2013: 369 · 2012: 376
FWCI: 292.60
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (UO1 HL55297, UO1 HL55496, UO1 HL55766, U01HL055297, U01HL055766, U01HL055496)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: amiodarone, implantable cardioverter-defibrillator, congestive heart failure, sudden cardiac death, mortality, left ventricular ejection fraction, NYHA functional class, antiarrhythmic therapy
MeSH terms: Aged, Amiodarone, Anti-Arrhythmia Agents, Cause of Death, Female, Heart Failure, Humans, Male, Middle Aged, Risk, Stroke Volume, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks